CAS 532959-63-0

Methanesulfonamide,N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]-

Description:

Methanesulfonamide, N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]- is a chemical compound characterized by its complex structure, which includes a methanesulfonamide group and a substituted imidazoquinoline moiety. This compound is typically recognized for its potential biological activity, particularly in medicinal chemistry, where it may exhibit properties relevant to pharmacological applications. The presence of the imidazoquinoline structure suggests potential interactions with biological targets, possibly influencing cellular pathways or exhibiting anti-cancer properties. The methanesulfonamide group contributes to its solubility and reactivity, making it a candidate for further research in drug development. Additionally, the compound's specific functional groups may impart unique characteristics such as hydrogen bonding capabilities and steric effects, which can influence its pharmacokinetics and pharmacodynamics. Overall, this compound represents a class of molecules that are of interest in the development of therapeutic agents, particularly in oncology or related fields.

Formula: C₁₇H₂₃N₅O₂S

PF-4878691

CAS: 532959-63-0

PF-4878691 (3M-852A) is an effective and selective Toll-like receptor 7 agonists modelled. It is used to dissociate its antiviral and inflammatory activities.

Formula: C₁₇H₂₃N₅O₂S

Purity: 98.43%

Color and Shape: Solid

Molecular weight: 361.46

Ref: TM-T16506

N-[4-(4-Amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]-methylesulfonamide

CAS: 532959-63-0

Formula: C₁₇H₂₃N₅O₂S

Purity: 98%

Color and Shape: Solid

Molecular weight: 361.4618

Ref: IN-DA01EFH5

N-(4-(4-Amino-2-Ethyl-1H-Imidazo[4,5-C]Quinolin-1-Yl)Butyl)Methanesulfonamide

CAS: 532959-63-0

N-(4-(4-Amino-2-Ethyl-1H-Imidazo[4,5-C]Quinolin-1-Yl)Butyl)Methanesulfonamide

Purity: 98%

Molecular weight: 361.46g/mol

Ref: 54-OR1023840

PF-4878691

CAS: 532959-63-0

PF-4878691

Purity: ≥98%

Molecular weight: 361.46g/mol

Ref: 54-BUP05569

N-[4-(4-Amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]-methylesulfonamide

CAS: 532959-63-0

N-{4-[4-amino-2-(ethyl)-1H-imidazo[4,5-c]quinolin-1-yl]butyl}methylesulfonamide (AEMI) is a novel immunomodulator that has been shown to have anticarcinogenic effects in preclinical studies. It induces an immune response in patients with cancer by stimulating the production of interleukin 1 receptor antagonist and other cytokines. AEMI also activates toll-like receptor 2, which is involved in the innate immunity pathway and triggers an orchestrated immune response to destroy tumour cells. The clinical response to AEMI is dose proportional and shows no adverse effects on healthy cells or tissues.

Purity: Min. 95%

Ref: 3D-NA162905